BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 28130808)

  • 1. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
    Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
    Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease.
    Shimizu S; Hirao K; Kanetaka H; Namioka N; Hatanaka H; Hirose D; Fukasawa R; Umahara T; Sakurai H; Hanyu H
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):184-192. PubMed ID: 26233438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the usefulness of brain perfusion SPECT and MIBG myocardial scintigraphy for the diagnosis of dementia with Lewy bodies.
    Tateno M; Kobayashi S; Shirasaka T; Furukawa Y; Fujii K; Morii H; Yasumura S; Utsumi K; Saito T
    Dement Geriatr Cogn Disord; 2008; 26(5):453-7. PubMed ID: 18974648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study.
    Tiraboschi P; Corso A; Guerra UP; Nobili F; Piccardo A; Calcagni ML; Volterrani D; Cecchin D; Tettamanti M; Antelmi L; Vidale S; Sacco L; Merello M; Stefanini S; Micheli A; Vai P; Capitanio S; Gabanelli SV; Riva R; Pinto P; Biffi AM; Muscio C;
    Ann Neurol; 2016 Sep; 80(3):368-78. PubMed ID: 27398636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Hanyu H; Shimizu S; Hirao K; Kanetaka H; Iwamoto T; Chikamori T; Usui Y; Yamashina A; Koizumi K; Abe K
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):248-53. PubMed ID: 16328506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improved diagnosis of dementia with Lewy bodies by the combination of 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 99mTc-ethylcysteinate dimmer (ECD) brain perfusion SPECT].
    Kobayashi S; Tateno M; Furukawa Y; Shirasaka T; Utumi K
    Seishin Shinkeigaku Zasshi; 2008; 110(4):285-91. PubMed ID: 18593002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index.
    Sakamoto F; Shiraishi S; Ogasawara K; Tsuda N; Nakagawa M; Tomiguchi S; Yamashita Y
    Ann Nucl Med; 2020 Jun; 34(6):415-423. PubMed ID: 32301068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
    Inui Y; Toyama H; Manabe Y; Sato T; Sarai M; Kosaka K; Iwata N; Katada K
    J Nucl Med; 2007 Oct; 48(10):1641-50. PubMed ID: 17873141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
    Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
    J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [
    Fujishiro H; Okuda M; Iwamoto K; Miyata S; Torii Y; Iritani S; Ozaki N
    Psychiatry Clin Neurosci; 2018 Jun; 72(6):423-434. PubMed ID: 29536584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of dementia with Lewy bodies: can
    Sakamoto F; Shiraishi S; Tsuda N; Hashimoto M; Tomiguchi S; Ikeda M; Yamashita Y
    Br J Radiol; 2017 Feb; 90(1070):20160156. PubMed ID: 27897064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of (123)I-MIBG myocardial scintigraphy, brain perfusion SPECT, and voxel-based MRI morphometry for distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    Inui Y; Toyama H; Manabe Y; Sarai M; Iwata N
    Ann Nucl Med; 2014 Oct; 28(8):796-804. PubMed ID: 24986482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.
    McKeith I; O'Brien J; Walker Z; Tatsch K; Booij J; Darcourt J; Padovani A; Giubbini R; Bonuccelli U; Volterrani D; Holmes C; Kemp P; Tabet N; Meyer I; Reininger C;
    Lancet Neurol; 2007 Apr; 6(4):305-13. PubMed ID: 17362834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.
    McCleery J; Morgan S; Bradley KM; Noel-Storr AH; Ansorge O; Hyde C
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010633. PubMed ID: 25632881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of dementia with Lewy bodies: diagnostic performance of combined ¹²³I-IMP brain perfusion SPECT and ¹²³I-MIBG myocardial scintigraphy.
    Sakamoto F; Shiraishi S; Yoshida M; Tomiguchi S; Hirai T; Namimoto T; Hashimoto M; Ikeda M; Uetani H; Yamashita Y
    Ann Nucl Med; 2014 Apr; 28(3):203-11. PubMed ID: 24363079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging for diagnosing dementia with Lewy bodies: What is the best neuroimaging technique in discriminating dementia with Lewy bodies from Alzheimer's disease?
    Shimizu S; Kanetaka H; Hirao K; Fukasawa R; Namioka N; Hatanaka H; Hirose D; Umahara T; Sakurai H; Hanyu H
    Geriatr Gerontol Int; 2017 May; 17(5):819-824. PubMed ID: 27138074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial scintigraphy may predict the conversion to probable dementia with Lewy bodies.
    Oda H; Ishii K; Terashima A; Shimada K; Yamane Y; Kawasaki R; Ohkawa S
    Neurology; 2013 Nov; 81(20):1741-5. PubMed ID: 24122183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of dopamine transporter imaging (DAT-SPECT) and
    Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
    J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.
    Lebasnier A; Lamotte G; Manrique A; Peyronnet D; Bouvard G; Defer G; Agostini D
    Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1043-51. PubMed ID: 25626701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical imaging in dementia with Lewy bodies.
    Surendranathan A; O'Brien JT
    Evid Based Ment Health; 2018 May; 21(2):61-65. PubMed ID: 29602778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.